References
- FleischmannRMTesserJSchiffMHSafety of extended treatment with anakinra in patients with rheumatoid arthritisAnn Rheum Dis2006651006101216396977
- DonahueKEGartlehnerGJonasDESystemic review: Comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritisAnn Intern Med200814812413418025440
- MertensMSinghJAAnakinra for rheumatoid arthritisCochrane Database Syst Rev20091CD00512119160248
- WeismanMHWhat are the risks of biological therapy in RA? An update on safetyJ Rheumatol Suppl200265333812236621
- GenoveseMCCohenSMorelandLCombination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateArthritis Rheum2004501412141915146410
- Juhan-VagueIAlessiMCMavriAMorangePEPlasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular riskJ Thromb Haemost200311575157912871293
- CunnaneGMadiganAMurphyEFitzGeraldOBresnihanBThe effect of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritisRheumatology (Oxford)200140626911157143
- Gewiese-RabschJDruckerCMalchowSSchellerJRose-JohnSRole of IL-6 trans-signaling in CCl4 induced liver damageBiochim Biophys Acta201018021054106120691261
- GarceaGMaddernGJLiver failure after major hepatic resectionJ Hepatobiliary Pancreat Surg20091614515519110651
- LamSPLukJMManKActivation of interleukin-6 induced glycoprotein 130/signal transducer and activation of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regenerationLiver Transpl2010161195120620879018
- CressmanDEGreenbaumLEDeAngelisRALiver failure and defective hepatocyte regeneration in interleukin-6-deficient miceScience1996247137913838910279
- MosmannTRMoorKWThe role of IL-10 in crossregulation of TH1 and TH2 responsesImmunol Today199112A49A531648926